Rayno BioBeat #3: Choppy Days are Ahead but Still Looks Bullish…Update-3 vaccine sell-off
8/11/21 2p EDT...A sea of red in most smaller cap biotech stocks but market overall is holding up nicely. The normally stable IBB is down over 3.5% so must be the inclusion of MRNA? BNTX is down 18% to $340! Large cap biopharma is holding up except Pfizer (PFE) is down 3.62% probably related...
Healthcare Stocks Are Tracking Well Despite Biotech Lagging
Healthcare Stocks Are Tracking Well-Indices are at Record Highs Look to Large Cap Biopharma earnings in coming weeks. Pfizer on Wednesday. Momentum in speculative small caps are lagging so may need to wait for Q4. Macro concerns lie ahead: China, Infrastructure deal and delta variant. Our...
What Did I Miss While on Vacation Last Week?… Market WRAP July 20…Update-3
Update-3 JY 20...a good reversal day! Our healthcare portfolio strategy is working well even on volatile days.All major averages were up about 1.5% today and most biotechs did better.The XLV was up 1.2% to $128.82.We will post a new article at the end of the week.Some notable moves for today:...
Mid-Cap Biotech Picks: Seasonal Rally Underway…Update-1
Update-1 8:45am Vacation through Friday:Asia down, Futures down over 1% on growth concerns. Technicals look toppy on ARKG and XBI. New Mid-Cap Biotech Picks Momentum indicators for tracking and trading:ARKG and XBI. All three recent mid-cap biotech picks are up since end of May. Biotech sector...
Healthcare Portfolio Playbook On a Broad Rally Week…Update-1
Update-1 June 29 The Momentum indicators for biotech: ARKG was flat at $9310, XBI down 1.53% to $135.74. COVID Dx stocks were stronger ABT up 1.31% to $117.21, QDEL up 3.97% to $132.12. COVID Vaccine stocks CVAC, MRNA and NVAX were strong. Our new mid-cap picks were weak: CRSP down 0.75% to...